KELLY SHAKYA: Open Payments
NPI 1083386486 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $418 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 2 | $247 |
| Edwards Lifesciences Corporation | 1 | $150 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Lilly USA, LLC | 2 | $53 |
| ABIOMED | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: FFRct, SAPIEN 3 Ultra RESILIA, MOUNJARO, TRELEGY ELLIPTA, SHINGRIX, APTIMA, FARXIGA, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
